Aytu BioScience, Inc. (AYTU) Social Stream



Aytu BioScience, Inc. (AYTU): $1.94

0.02 (+0.91%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add AYTU to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#38 of 345

in industry

Featured Post From StockTwits About AYTU

$SPY When Sterling Medical Devies get #HEALight from Cedars Siani FDA approved +50/PPS.

With successful AYTU+NEOS merger completed in end of March 2021. It now comes with projected 100M+ combined annual revenue. Also don't forget estimated 15M+ additional savings in synergies costs we will benefit from in the future.

$AYTU
21Q3: +13.48M
21Q2: +15.15M
21Q1: +13.52M
20Q4: +14.86M

$NEOS
20Q3: +12.54M
20Q2: +13.13M
20Q1: +14.49M
19Q4: +16.83M

I know multiple companies 2x-3x our market cap who has yet to produce revenue annually what we just produce quarterly, yet our market cap is below 100M.

Now I don't know about you but it seems awfully little suspicious to me with constant manipulation here from price suppression and lack of management oversight deliberately intended to shake out retail investors.

This must truly be POS company with billion dollar hedge fund Armistice sitting as our BOD from the beginning. As Cantor and HCW along with other institutions still in it I wonder why.
QuantScalper, published August 14, 2021

What Else are AYTU Traders Talking About?


Other tickers frequently mentioned alongside AYTU is SPY.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!